Mimedx (MDXG) Profit After Tax (2011 - 2026)

Mimedx has disclosed Profit After Tax across 16 years of filings, most recently posting -$10.9 million for Q1 2026.

• Profit After Tax for Q1 2026 came in at -$10.9 million, down 254.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $30.7 million (down 23.19% YoY), and the FY2025 annual result was $48.6 million, up 15.67% from the prior year.
• Profit After Tax came in at -$10.9 million for Q1 2026 at Mimedx, down from $15.2 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $62.7 million in Q4 2023 to a low of -$10.9 million in Q2 2022.
• The 5-year median for Profit After Tax is $7.4 million (2024), against an average of $7.1 million.
• Across the five-year window, Profit After Tax slumped 510.91% in 2022 and soared 15242.03% in 2023, its largest moves.
• Mimedx's Profit After Tax stood at -$414000.0 in 2022, then jumped by 15242.03% to $62.7 million in 2023, then plunged by 88.13% to $7.4 million in 2024, then surged by 104.24% to $15.2 million in 2025, then plunged by 171.49% to -$10.9 million in 2026.
• The last three Profit After Tax figures came in at -$10.9 million (Q1 2026), $15.2 million (Q4 2025), and $16.7 million (Q3 2025), per Business Quant data.